Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone for Prevention of Preterm Birth in Women With Short Cervix
NCT00422526Phase 3Completed
- Sponsor
- King's College Hospital
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in preterm birth comparing Progesterone with Placebo (2 arms). Primary endpoint: Spontaneous delivery before 34 completed weeks (238 days) of gestation. Started Sep 2003; status: completed.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT00422526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422526.